BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 6, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for March 10, 2025

March 10, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lunit, Medtronic.
Read More

In the clinic for March 7, 2025

March 7, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Denali, ITM, Medicus, Tris.
Read More

In the clinic for March 6, 2025

March 6, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acadia, Bloom, Cantargia, Celon, Clarity, Irlab, Lygenesis, Persica.
Read More

In the clinic for March 6, 2025

March 6, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Magnolia Medical.
Read More

In the clinic for March 5, 2025

March 5, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Lexicon, Pepgen.
Read More

In the clinic for March 4, 2025

March 4, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acadia, Apogee, Amgen, Astrazeneca, Biohaven, Celldex, Daiichi Sankyo, Enlivex, Genentech, GSK, Nicox, Opthea, Perfuse, Pharvaris, Pliant, Protagonist, Saniona, Takeda, Voyager, Y-mabs.
Read More

In the clinic for March 4, 2025

March 4, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Inspira.
Read More

In the clinic for March 4, 2025

March 4, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Biocity, Cstone, Delta-Fly, Innocare, Yoltech.
Read More

In the clinic for March 3, 2025

March 3, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alumis, Delta-Fly, Nanomerics, Praxis, Virpax.
Read More

In the clinic for Feb. 28, 2025

Feb. 28, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amarin, Belite Bio, Cogent, Irlab, Kallyope, Leo, Quoin.
Read More
Previous 1 2 … 41 42 43 44 45 46 47 48 49 … 315 316 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Illustration of liver being targets with cross-hairs

    Study identifies CAND1 as therapeutic target in hepatoblastoma

    BioWorld Science
    Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing